Search research articles
Contact Us
Filters
Showing results (191-200 of 221) with videos related to
Page
of 23
Sort By:
The Journal of Biological Chemistry
|
October 21, 2023
A highly specific antibody against the core fucose of the N-glycan in IgG identifies the pulmonary diseases and its regulation by CCL2
Noriko Kanto, Yuki Ohkawa, Masato Kitano, et al.
Respiratory Investigation
|
March 14, 2024
Japanese guidelines for the treatment of idiopathic pulmonary fibrosis 2023:Revised edition
Masashi Bando, Sakae Homma, Hiroshi Date, et al.
The European Respiratory Journal
|
March 26, 2026
Nerandomilast in progressive pulmonary fibrosis: data from the whole follow-up period of the FIBRONEER-ILD trial
Marlies S Wijsenbeek, Shervin Assassi, Arata Azuma, et al.
The New England Journal of Medicine
|
May 22, 2019
Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease
Oliver Distler, Kristin B Highland, Martina Gahlemann, et al.
BMC Pulmonary Medicine
|
June 29, 2014
An autopsy study of combined pulmonary fibrosis and emphysema: correlations among clinical, radiological, and pathological features
Minoru Inomata, Soichiro Ikushima, Nobuyasu Awano, et al.
Scientific Reports
|
May 31, 2024
Blood perfusion with polymyxin B immobilized columns in patients with COVID-19 requiring oxygen therapy
Daisuke Katagiri, Akinari Tsukada, Shinyu Izumi, et al.
Respiratory Research
|
April 26, 2018
Resolution of bleomycin-induced murine pulmonary fibrosis via a splenic lymphocyte subpopulation
Koichiro Kamio, Arata Azuma, Kuniko Matsuda, et al.
BMJ Open Respiratory Research
|
September 14, 2023
Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with progressive pulmonary fibrosis (FIBRONEER-ILD)
Toby M Maher, Shervin Assassi, Arata Azuma, et al.
The New England Journal of Medicine
|
May 19, 2025
Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis
Luca Richeldi, Arata Azuma, Vincent Cottin, et al.
Cureus
|
March 14, 2025
Inflammatory and Coagulation Marker Changes in PMX-DHP-Treated COVID-19 Patients
Akinari Tsukada, Daisuke Katagiri, Shinyu Izumi, et al.
Page
of 23
Search research articles
Search
Showing results (191-200 of 221) with videos related to
Sort By:
Page
of 23
The Journal of Biological Chemistry
|
October 21, 2023
A highly specific antibody against the core fucose of the N-glycan in IgG identifies the pulmonary diseases and its regulation by CCL2
Noriko Kanto, Yuki Ohkawa, Masato Kitano, et al.
Respiratory Investigation
|
March 14, 2024
Japanese guidelines for the treatment of idiopathic pulmonary fibrosis 2023:Revised edition
Masashi Bando, Sakae Homma, Hiroshi Date, et al.
The European Respiratory Journal
|
March 26, 2026
Nerandomilast in progressive pulmonary fibrosis: data from the whole follow-up period of the FIBRONEER-ILD trial
Marlies S Wijsenbeek, Shervin Assassi, Arata Azuma, et al.
The New England Journal of Medicine
|
May 22, 2019
Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease
Oliver Distler, Kristin B Highland, Martina Gahlemann, et al.
BMC Pulmonary Medicine
|
June 29, 2014
An autopsy study of combined pulmonary fibrosis and emphysema: correlations among clinical, radiological, and pathological features
Minoru Inomata, Soichiro Ikushima, Nobuyasu Awano, et al.
Scientific Reports
|
May 31, 2024
Blood perfusion with polymyxin B immobilized columns in patients with COVID-19 requiring oxygen therapy
Daisuke Katagiri, Akinari Tsukada, Shinyu Izumi, et al.
Respiratory Research
|
April 26, 2018
Resolution of bleomycin-induced murine pulmonary fibrosis via a splenic lymphocyte subpopulation
Koichiro Kamio, Arata Azuma, Kuniko Matsuda, et al.
BMJ Open Respiratory Research
|
September 14, 2023
Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with progressive pulmonary fibrosis (FIBRONEER-ILD)
Toby M Maher, Shervin Assassi, Arata Azuma, et al.
The New England Journal of Medicine
|
May 19, 2025
Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis
Luca Richeldi, Arata Azuma, Vincent Cottin, et al.
Cureus
|
March 14, 2025
Inflammatory and Coagulation Marker Changes in PMX-DHP-Treated COVID-19 Patients
Akinari Tsukada, Daisuke Katagiri, Shinyu Izumi, et al.
Page
of 23